.jpg?format=webp&quality=80&width=3840)
The study found that the type 1 interferon (IFN) pathway is significantly increased in dermatomyositis (DM) patients. By analyzing 355 blood samples from 202 well-studied DM patients, they discovered a distinct IFN-driven transcriptional response pattern resembling systemic lupus erythematosus. Interestingly, the IFN score showed variation depending on the presence of specific autoantibodies. Notably, skin and muscle disease activity, interstitial lung disease, and anti–melanoma differentiation–associated protein 5 (anti–MDA‐5) antibodies were independently associated with the IFN score.
Like
Save
Share